FigureĀ 1.
CONSORT diagram description of the patient cohort. Patients were censored at time of death or 7 days after progressive disease (PD). CRS, cytokine release syndrome; Flu/Cy, fludarabine and cyclophosphamide; ide-cel, idecabtagene vicleucel; LD, lymphodepletion chemotherapy.

CONSORT diagram description of the patient cohort. Patients were censored at time of death or 7 days after progressive disease (PD). CRS, cytokine release syndrome; Flu/Cy, fludarabine and cyclophosphamide; ide-cel, idecabtagene vicleucel; LD, lymphodepletion chemotherapy.

Close Modal

or Create an Account

Close Modal
Close Modal